Pharmaco - Press Releases

Date	Title	Company
20-Jan-2021	Data published in Molecular Diagnostics & Therapy demonstrate how Secarna's powerful bioinformatics generate improved LNA-modified antisense oligonucleotide therapies	Secarna Pharmaceuticals GmbH & Co. KG
20-Jan-2021	Impel NeuroPharma Announces U.S. Food & Drug Administration Acceptance of New Drug Application for INP104 for the Acute Treatment of Migraine	B3C newswire
20-Jan-2021	Syntekabio and Hanmi Science Join Forces to Co-Develop New Promising COVID-19 Treatments Using Drug Repurposing Technologies	Syntekabio
20-Jan-2021	Worldwide Drug Delivery Systems Market research report 2021 - Business Growth Prospect and Opportunities by 2030	Prudour Pvt Ltd
20-Jan-2021	Evolva launches L-arabinose, a natural sugar blocker and reducing sugar	Evolva Holding SA
20-Jan-2021	Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil	RELIEF THERAPEUTICS Holdings AG
20-Jan-2021	Enalare Therapeutics Appoints Mark Coleman M.D. to Its Board of Directors	Enalare Therapeutics
19-Jan-2021	U.S. Centers for Medicare & Medicaid Services publish negative NCD for Epi proColon	Epigenomics AG
19-Jan-2021	Genmab Announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis	Genmab
19-Jan-2021	Khondrion receives EMA agreement on its Paediatric Investigation Plan for sonlicromanol	Khondrion
19-Jan-2021	SMC accepts Takeda’s ALUNBRIG▼(brigatinib) and ADCETRIS▼(brentuximab vedotin) for use in NHS Scotland for two rare cancers	Takeda
19-Jan-2021	Antibiotic Research UK welcomes new INEOS Oxford Institute to combat antimicrobial resistance as an important step forward	Sciad Newswire
19-Jan-2021	The biotech company baseclick GmbH launched a new and highly efficient method for SARS-CoV-2 mutation analysis	baseclick GmbH
19-Jan-2021	Antisense oligonucleotide candidate derived from Secarna Pharmaceuticals' LNAplusTM platform has entered pre-clinical safety trials for the treatment of elevated blood lipids	Secarna Pharmaceuticals GmbH & Co. KG
19-Jan-2021	Dirk Dembski new CEO at curasan AG	curasan AG
18-Jan-2021	Implandata’s EYEMATE System Protects Glaucoma Patients – Even During Lockdown	B3C newswire
18-Jan-2021	The RSA Group welcomes Eleanor Davies as Managing Partner	Sciad Newswire
18-Jan-2021	Antibiotic Research UK announces the appointment of Mr. Simon Dukes as Chair Designate of the Board of Trustees	Sciad Newswire
17-Jan-2021	Registration Opens for SMi’s 5th Annual Highly Potent Active Pharmaceutical Ingredients Conference (HPAPi)	SMi Group
14-Jan-2021	Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases	Ubiquigent